XENON PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
XENON PHARMACEUTICALS INC. (XENE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.50 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 131.90K shares, a 73.03% decline year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.37M shares, a 26.53% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 452.46K shares, a 117.42% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 79.50K shares, a 82.98% decline year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.89M shares, a 5.51% decline from fiscal 2024.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.06M shares, a 20.47% increase from fiscal 2023.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.54M shares, a 9.80% increase from fiscal 2022.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.32M shares, a 30.43% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 131.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 2.50M shares 10-Q · filed 2026-08-06 | 2.95M shares derived: sum of 3 quarters · filed 2026-08-06 | 3.03M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 2.37M shares 10-Q · filed 2026-05-07 | 2.82M shares derived: sum of 2 quarters · filed 2026-05-07 | 2.90M shares derived: sum of 3 quarters · filed 2026-05-07 | 3.39M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 452.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 531.96K shares derived: sum of 2 quarters · filed 2026-02-26 | 1.02M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.89M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 79.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 568.63K shares derived: sum of 2 quarters · filed 2026-08-06 | 2.44M shares 10-Q · filed 2025-11-03 | 2.65M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 489.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 2.36M shares 10-Q · filed 2026-08-06 | 2.57M shares derived: sum of 3 quarters · filed 2026-08-06 | 3.04M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 1.87M shares 10-Q · filed 2026-05-07 | 2.08M shares derived: sum of 2 quarters · filed 2026-05-07 | 2.55M shares derived: sum of 3 quarters · filed 2026-05-07 | 2.95M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 208.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 675.20K shares derived: sum of 2 quarters · filed 2026-02-26 | 1.08M shares derived: sum of 3 quarters · filed 2026-02-26 | 3.06M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 467.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 871.19K shares derived: sum of 2 quarters · filed 2025-11-03 | 2.85M shares 10-Q · filed 2025-11-03 | 2.94M shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 404.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 2.39M shares 10-Q · filed 2025-08-11 | 2.47M shares derived: sum of 3 quarters · filed 2026-02-26 | 2.84M shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 1.98M shares 10-Q · filed 2025-05-12 | 2.07M shares derived: sum of 2 quarters · filed 2026-02-26 | 2.43M shares derived: sum of 3 quarters · filed 2026-02-26 | 2.66M shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 85.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 448.50K shares derived: sum of 2 quarters · filed 2026-02-26 | 675.92K shares derived: sum of 3 quarters · filed 2026-02-26 | 2.54M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 363.20K shares 10-Q · filed 2023-11-08 | 590.63K shares derived: sum of 2 quarters · filed 2023-11-08 | 2.46M shares 10-Q · filed 2024-11-12 | 2.69M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 227.43K shares 10-Q · filed 2023-08-09 | 2.09M shares 10-Q · filed 2024-08-08 | 2.33M shares derived: sum of 3 quarters · filed 2025-02-27 | 2.43M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 1.87M shares 10-Q · filed 2024-05-09 | 2.10M shares derived: sum of 2 quarters · filed 2025-02-27 | 2.20M shares derived: sum of 3 quarters · filed 2025-02-27 | 2.52M shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 235.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 337.80K shares derived: sum of 2 quarters · filed 2025-02-27 | 655.80K shares derived: sum of 3 quarters · filed 2025-02-27 | 2.32M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 102.00K shares 10-Q · filed 2023-11-08 | 420.00K shares derived: sum of 2 quarters · filed 2023-11-08 | 2.08M shares 10-Q · filed 2023-11-08 | 2.12M shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 318.00K shares 10-Q · filed 2023-08-09 | 1.98M shares 10-Q · filed 2023-08-09 | 2.02M shares derived: sum of 3 quarters · filed 2024-02-29 | 2.26M shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 1.66M shares 10-Q · filed 2023-05-09 | 1.70M shares derived: sum of 2 quarters · filed 2024-02-29 | 1.94M shares derived: sum of 3 quarters · filed 2024-02-29 | 2.32M shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 44.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 281.00K shares derived: sum of 2 quarters · filed 2024-02-29 | 663.50K shares derived: sum of 3 quarters · filed 2024-02-29 | 1.78M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 236.20K shares 10-Q · filed 2022-11-08 | 618.70K shares derived: sum of 2 quarters · filed 2022-11-08 | 1.73M shares 10-Q · filed 2022-11-08 | 1.77M shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 382.50K shares 10-Q · filed 2022-08-09 | 1.49M shares 10-Q · filed 2022-08-09 | 1.54M shares derived: sum of 3 quarters · filed 2023-03-01 | 1.73M shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 1.11M shares 10-Q · filed 2022-05-10 | 1.15M shares derived: sum of 2 quarters · filed 2023-03-01 | 1.35M shares derived: sum of 3 quarters · filed 2023-03-01 | 1.48M shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 42.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 236.60K shares derived: sum of 2 quarters · filed 2023-03-01 | 363.90K shares derived: sum of 3 quarters · filed 2023-03-01 | 1.48M shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 194.40K shares 10-Q · filed 2021-11-10 | 321.70K shares derived: sum of 2 quarters · filed 2021-11-10 | 1.44M shares 10-Q · filed 2021-11-10 | 1.46M shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 127.30K shares 10-Q · filed 2021-08-11 | 1.25M shares 10-Q · filed 2021-08-11 | 1.27M shares derived: sum of 3 quarters · filed 2021-08-11 | 2.45M shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | 1.12M shares 10-Q · filed 2021-05-11 | 1.14M shares derived: sum of 2 quarters · filed 2021-05-11 | 2.32M shares derived: sum of 3 quarters · filed 2021-05-11 | 2.32M shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | 23.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 1.20M shares derived: sum of 2 quarters · filed 2021-03-01 | 1.20M shares derived: sum of 3 quarters · filed 2021-03-01 | 1.23M shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 1.18M shares 10-Q · filed 2020-11-05 | 1.18M shares derived: sum of 2 quarters · filed 2020-11-05 | 1.20M shares 10-Q · filed 2020-11-05 | 1.21M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2020-08-06 | 21.90K shares 10-Q · filed 2020-08-06 | 30.05K shares derived: sum of 3 quarters · filed 2020-08-06 | 42.05K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | 21.90K shares 10-Q/A · filed 2020-05-26 | 30.05K shares derived: sum of 2 quarters · filed 2020-05-26 | 42.05K shares derived: sum of 3 quarters · filed 2020-05-26 | 164.80K shares derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-12-31 | 8.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 20.15K shares derived: sum of 2 quarters · filed 2020-03-09 | 142.90K shares derived: sum of 3 quarters · filed 2020-03-09 | 706.60K shares 10-K · filed 2020-03-09 |
| 2018-09-30 | 12.00K shares 10-Q · filed 2019-11-05 | 134.75K shares derived: sum of 2 quarters · filed 2019-11-05 | 698.45K shares 10-Q · filed 2019-11-05 | 871.85K shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | 122.75K shares 10-Q · filed 2019-08-06 | 686.45K shares 10-Q · filed 2019-08-06 | 859.85K shares derived: sum of 3 quarters · filed 2019-08-06 | 860.90K shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | 563.70K shares 10-Q · filed 2019-05-07 | 737.10K shares derived: sum of 2 quarters · filed 2019-05-07 | 738.15K shares derived: sum of 3 quarters · filed 2019-05-07 | 767.90K shares derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | 173.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 174.45K shares derived: sum of 2 quarters · filed 2019-03-06 | 204.20K shares derived: sum of 3 quarters · filed 2019-03-06 | 620.95K shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 1.05K shares 10-Q · filed 2018-11-06 | 30.80K shares derived: sum of 2 quarters · filed 2018-11-06 | 447.55K shares 10-Q · filed 2018-11-06 | 449.90K shares derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | 29.75K shares 10-Q · filed 2018-08-07 | 446.50K shares 10-Q · filed 2018-08-07 | 448.85K shares derived: sum of 3 quarters · filed 2018-08-07 | 470.89K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | 416.75K shares 10-Q · filed 2018-05-08 | 419.10K shares derived: sum of 2 quarters · filed 2018-05-08 | 441.14K shares derived: sum of 3 quarters · filed 2018-05-08 | 506.59K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | 2.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 24.39K shares derived: sum of 2 quarters · filed 2018-03-07 | 89.84K shares derived: sum of 3 quarters · filed 2018-03-07 | 323.79K shares 10-K · filed 2018-03-07 |
| 2016-09-30 | 22.04K shares 10-Q · filed 2017-11-07 | 87.49K shares derived: sum of 2 quarters · filed 2017-11-07 | 321.44K shares 10-Q · filed 2017-11-07 | 466.19K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 65.45K shares 10-Q · filed 2017-08-03 | 299.40K shares 10-Q · filed 2017-08-03 | 444.15K shares derived: sum of 3 quarters · filed 2018-03-07 | 448.25K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 233.95K shares 10-Q · filed 2017-05-09 | 378.70K shares derived: sum of 2 quarters · filed 2018-03-07 | 382.80K shares derived: sum of 3 quarters · filed 2018-03-07 | 416.27K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 144.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 148.85K shares derived: sum of 2 quarters · filed 2018-03-07 | 182.32K shares derived: sum of 3 quarters · filed 2018-03-07 | 529.29K shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 4.10K shares 10-Q · filed 2016-11-03 | 37.57K shares derived: sum of 2 quarters · filed 2016-11-03 | 384.54K shares 10-Q · filed 2016-11-03 | 426.20K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-06-30 | 33.47K shares 10-Q · filed 2016-08-03 | 380.44K shares 10-Q · filed 2016-08-03 | 422.10K shares derived: sum of 3 quarters · filed 2017-03-08 | 428.38K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-03-31 | 346.96K shares 10-Q · filed 2016-05-10 | 388.63K shares derived: sum of 2 quarters · filed 2017-03-08 | 394.90K shares derived: sum of 3 quarters · filed 2017-03-08 | 394.90K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | 41.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | 47.94K shares derived: sum of 2 quarters · filed 2017-03-08 | 47.94K shares derived: sum of 3 quarters · filed 2017-03-08 | 205.17K shares 10-K · filed 2017-03-08 |
| 2014-09-30 | 6.27K shares 10-Q · filed 2015-11-10 | 6.27K shares derived: sum of 2 quarters · filed 2015-11-10 | 163.50K shares 10-Q · filed 2015-11-10 | 163.50K shares derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-13 | 157.23K shares 10-Q · filed 2015-08-13 | 157.23K shares derived: sum of 3 quarters · filed 2016-03-08 | 199.82K shares derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | 157.23K shares 10-Q/A · filed 2015-08-13 | 157.23K shares derived: sum of 2 quarters · filed 2016-03-08 | 199.82K shares derived: sum of 3 quarters · filed 2016-03-08 | |
| 2013-12-31 | 1.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | 42.59K shares derived: sum of 2 quarters · filed 2016-03-08 | 292.42K shares 10-K · filed 2016-03-08 | |
| 2013-09-30 | 42.59K shares 10-Q · filed 2014-12-15 | 292.42K shares 10-Q · filed 2014-12-15 | ||
| 2012-12-31 | 150.10K shares 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |